Literature DB >> 29248893

Autoimmune nodo-paranodopathies of peripheral nerve: the concept is gaining ground.

Antonino Uncini1, Jean-Michel Vallat2.   

Abstract

Peripheral neuropathies are classified as primarily demyelinating or axonal. Microstructural alterations of the nodal region are the key to understand the pathophysiology of neuropathies with antibodies to gangliosides and the new category of nodo-paranodopathy has been proposed to better characterise these disorders and overcome some inadequacies of the dichotomous classification. Recently, the research in autoimmune neuropathies has been boosted by reports of patients carrying immunoglobulin G4 antibodies against paranodal axo-glial proteins with distinct phenotypes and showing loss of transverse bands, terminal myelin loop detachment, nodal widening and axonal loss. These patients have been classified up to now as chronic inflammatory demyelinating polyradiculoneuropathy but, in our opinion, better fit into the nodo-paranodopathy category because nerve injury is due to dismantling of the paranode, segmental de-remyelination is absent and the pathogenic mechanism is not inflammatory. Evidence from nerve conductions and electron microscopy studies in patients and mutant animal models can reconcile the apparent contrast between the electrophysiological 'demyelinating' features, explainable just by the paranodal involvement and the axonal pathology. These patients broaden the autoimmune nodo-paranodopathy category and re-emphasise the usage of the term that pointing to the site of nerve injury reminds specific pathophysiological mechanisms, reconciles contrasting electrophysiological and pathological findings, and avoids misdiagnosis and taxonomic confusion. In our opinion, the nodo-paranodopathy term more adequately classifies the peripheral nerve disorders due to an autoimmune attack directed and limited to the nodal region integrating the traditional classification of peripheral neuropathies. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  guillain-barre syndrome; neuropathy; neurophysiol, clinical

Mesh:

Year:  2017        PMID: 29248893     DOI: 10.1136/jnnp-2017-317192

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

Review 1.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

2.  Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo.

Authors:  Constance Manso; Luis Querol; Cinta Lleixà; Mallory Poncelet; Mourad Mekaouche; Jean-Michel Vallat; Isabel Illa; Jérôme J Devaux
Journal:  J Clin Invest       Date:  2019-03-14       Impact factor: 14.808

Review 3.  Anti-complement Agents for Autoimmune Neurological Disease.

Authors:  Jennifer A McCombe; Sean J Pittock
Journal:  Neurotherapeutics       Date:  2022-05-12       Impact factor: 6.088

Review 4.  Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.

Authors:  Lisha Tang; Qianyi Huang; Zhen Qin; Xiangqi Tang
Journal:  J Neurol       Date:  2020-04-07       Impact factor: 4.849

Review 5.  Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies.

Authors:  Johannes J Roggenbuck; Joseph Boucraut; Emilien Delmont; Karsten Conrad; Dirk Roggenbuck
Journal:  Ann Transl Med       Date:  2018-09

Review 6.  The ataxic neuropathies.

Authors:  Stéphane Mathis; Fanny Duval; Antoine Soulages; Guilhem Solé; Gwendal Le Masson
Journal:  J Neurol       Date:  2020-06-15       Impact factor: 4.849

7.  Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy.

Authors:  Diamantis Athanasopoulos; Jeremias Motte; Anna Lena Fisse; Thomas Grueter; Nadine Trampe; Dietrich Sturm; Martin Tegenthoff; Melissa Sgodzai; Rafael Klimas; Luis Querol; Ralf Gold; Kalliopi Pitarokoili
Journal:  Ann Clin Transl Neurol       Date:  2020-05-20       Impact factor: 4.511

8.  Reversible conduction failure on the deep tendon reflex response recording in early Guillain-Barré syndrome.

Authors:  Antonio García; María J Sedano; Silvia Álvarez-Paradelo; José Berciano
Journal:  Clin Neurophysiol Pract       Date:  2018-11-03

9.  Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy.

Authors:  Helena Stengel; Atay Vural; Anna-Michelle Brunder; Annika Heinius; Luise Appeltshauser; Bianca Fiebig; Florian Giese; Christian Dresel; Aikaterini Papagianni; Frank Birklein; Joachim Weis; Tessa Huchtemann; Christian Schmidt; Peter Körtvelyessy; Carmen Villmann; Edgar Meinl; Claudia Sommer; Frank Leypoldt; Kathrin Doppler
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-08-16

10.  Miller Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome overlap with persistent non-demyelinating conduction blocks: a case report.

Authors:  Angela Puma; Jeanne Benoit; Sabrina Sacconi; Antonino Uncini
Journal:  BMC Neurol       Date:  2018-07-21       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.